Rothstein, Brooke. “Topical JAK Inhibitor Ruxolitinib for Vitiligo Treatment”. SKIN The Journal of Cutaneous Medicine 2 (December 17, 2018): S110-S111. Accessed July 22, 2024. https://jofskin.org/index.php/skin/article/view/451.